| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Labetalol hydrochloride |
Is a |
False |
Labetalol (substance) |
Inferred relationship |
Some |
|
| Labetalol measurement |
Component |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Labetalol adverse reaction (disorder) |
Causative agent (attribute) |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Allergy to labetalol (finding) |
Causative agent (attribute) |
False |
Labetalol (substance) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide + labetalol hydrochloride 25mg/200mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol (substance) |
Inferred relationship |
Some |
|
| Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol (substance) |
Inferred relationship |
Some |
|
| Product containing labetalol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Product containing hydrochlorothiazide and labetalol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Labetalol (substance) |
Inferred relationship |
Some |
|
| Allergy to labetalol (finding) |
Causative agent (attribute) |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Product containing hydrochlorothiazide and labetalol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Labetalol hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
|
| Product containing hydrochlorothiazide and labetalol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Product containing labetalol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Product containing labetalol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide and labetalol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Labetalol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Labetalol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Labetalol only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
| Hydrochlorothiazide and labetalol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Labetalol (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]